Skip to main navigation
Repare Therapeutics
  • Company
    • About Us
    • Leadership
    • Partnering
    • Contact
  • Science
    • Therapeutic Focus
    • Scientific References
  • Pipeline
    • Development Pipeline
    • Polθ Inhibitor
    • RP-1664 PLK4 inhibitor
    • Camonsertib ATR Inhibitor
  • Clinical Trials
    • Clinical Trials Overview
    • Expanded Access Policy
  • Careers
    • Job Opportunities
    • Our Culture
  • Investors & Media
    • Corporate Profile
    • Press Releases
    • Events & Presentations
      • Events
      • Presentations
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • SEC Filings
    • Corporate Governance
      • Documents & Charters
      • Management Team
      • Board of Directors
      • Committee Composition
      • Contact the Board
      • Entity report pursuant to Bill S-211
    • Investor Resources
      • Investor FAQs
      • Investor Email Alerts
      • PFIC Statement
      • Contact IR
Select Page

Committee Composition

Committee Composition

Independent Director Audit Committee Compensation Committee Nominating and Corporate Governance Committee Science & Technology Committee
David Bonita Independent Director Compensation Committee Science & Technology Committee
Thomas Civik Independent Director Audit Committee Nominating and Corporate Governance Committee
Samarth Kulkarni Independent Director Compensation Committee
Susan M. Molineaux, Ph.D. Independent Director Compensation Committee Science & Technology Committee
Ann D. Rhoads Independent Director Audit Committee Nominating and Corporate Governance Committee
Carol Schafer Independent Director Audit Committee Nominating and Corporate Governance Committee
Steven H. Stein Independent Director Science & Technology Committee
= Independent Director = Chairperson = Member
Media & IR Contact
Investor Relations & Media Contact

Steve Forte
Contact Us

Helpful Tools
  • Print Page
  • Email Alerts
  • RSS Feeds
Company
  • About Us
  • Leadership
  • Partnering
  • Contact
Science
  • Therapeutic Focus
  • Scientific References
Pipeline
  • Development Pipeline
  • Polθ Inhibitor
  • RP-1664 PLK4 inhibitor
  • Camonsertib ATR Inhibitor
Clinical Trials
  • Clinical Trials Overview
  • Expanded Access Policy
Careers
  • Job Opportunities
  • Our Culture
Investors & Media
  • Corporate Profile
  • Press Releases
  • Events & Presentations
  • Stock Information
  • SEC Filings
  • Corporate Governance
  • Investor Resources
Repare Therapeutics logo
© 2025 Repare Therapeutics
  • Privacy Policy
  • Terms of Use
  • Cookie Policy